- Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patientEynat Kedem
Institute of Clinical Immunology, Allergy and AIDS, Rambam Health Care Campus, Haifa, Israel
J Asthma 47:830-1. 2010..It is well known in asthmatic human immunodeficiency virus (HIV)-infected patients treated with inhaled fluticasone with ritonavir-containing antiretroviral regimen (cART)...
- Effect of HAART on salivary composition and oxidative profile in HIV-infected patientsEduardo Shahar
Institute of Allergy, Clinical Immunology and AIDS, Rambam Medical Center, Haifa, Israel
Curr HIV Res 6:447-51. 2008..Salivary collection is simple, non-invasive and not associated with risk of infection spread. Antioxidants in HIV patients may be recommended, as well as local oral means aimed at resuming salivary functions compromised in HIV patients...
- Successful desensitization protocol for hypersensitivity reaction caused by sunitinib in a patient with a gastrointestinal stromal tumorGil Bar-Sela
Division of Oncology, Rambam Health Care Campus and Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
Jpn J Clin Oncol 40:163-5. 2010..Oral desensitization appears to be an option for patients with hypersensitivity type I to sunitinib and may permit its safe administration to patients who experience HSR to this life-prolonging medication...
- Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian populationDoron M Behar
Molecular Medicine Laboratory, Rambam Health Care Campus, Haifa, Israel
Am J Nephrol 34:452-9. 2011....